Alpha Tau Medical Ltd. DRTS

Updated: 9 Aug 2026

NASDAQ | Biotech | Cancer radiation therapy development

No signal published yet

We already track Alpha Tau Medical and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Alpha Tau Medical free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Cancer radiation therapy development
We're already tracking Alpha Tau Medical Ltd. — here are the latest events we've registered

Recent News

  • In July 2026, Alpha Tau reported positive clinical trial results for its Alpha DaRT radiation therapy in combination with pembrolizumab for head and neck cancer, showing a 100% objective response rate in evaluable patients. The company also announced in July 2026 that it treated the first patient in its ADMIRE study for recurrent cutaneous squamous cell carcinoma.

What Firelda Watch includes for Alpha Tau Medical Ltd.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Alpha Tau Medical Ltd. will be delivered in the same format.

Want to follow Alpha Tau Medical Ltd.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Alpha Tau Medical free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Alpha Tau Medical Ltd. DRTS
Alpha Tau Medical — follow and we'll monitor it
Follow Alpha Tau Medical free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.